Dapagliflozin in patients with heart failure and reduced ejection fraction

Intern Emerg Med. 2020 Apr;15(3):515-517. doi: 10.1007/s11739-020-02297-0.
No abstract available

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Glucosides / therapeutic use*
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Placebos
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
  • Stroke Volume / drug effects*
  • Surveys and Questionnaires

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Placebos
  • Sodium-Glucose Transporter 2 Inhibitors
  • dapagliflozin